These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026 [TBL] [Abstract][Full Text] [Related]
7. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia. Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the MIR155 host gene in physiological and pathological processes. Elton TS; Selemon H; Elton SM; Parinandi NL Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696 [TBL] [Abstract][Full Text] [Related]
10. Serum microRNAs in clear cell carcinoma of the ovary. Chao A; Lai CH; Chen HC; Lin CY; Tsai CL; Tang YH; Huang HJ; Lin CT; Chen MY; Huang KG; Chou HH; Chang TC; Chen SJ; Wang TH Taiwan J Obstet Gynecol; 2014 Dec; 53(4):536-41. PubMed ID: 25510697 [TBL] [Abstract][Full Text] [Related]
11. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076 [TBL] [Abstract][Full Text] [Related]
12. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle. Filip AA; Grenda A; Popek S; Koczkodaj D; Michalak-Wojnowska M; Budzyński M; Wąsik-Szczepanek E; Zmorzyński S; Karczmarczyk A; Giannopoulos K Ann Hematol; 2017 Jan; 96(1):33-50. PubMed ID: 27730344 [TBL] [Abstract][Full Text] [Related]
13. Circulating serum miRNAs as potential biomarkers for nephroblastoma. Ludwig N; Nourkami-Tutdibi N; Backes C; Lenhof HP; Graf N; Keller A; Meese E Pediatr Blood Cancer; 2015 Aug; 62(8):1360-7. PubMed ID: 25787821 [TBL] [Abstract][Full Text] [Related]
14. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212. Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730 [TBL] [Abstract][Full Text] [Related]
15. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions. Xu Y; Zhang X; Pu S; Wu J; Lv Y; Du D Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):942-9. PubMed ID: 25274330 [TBL] [Abstract][Full Text] [Related]
17. Expression of microRNAs in basal cell carcinoma. Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308 [TBL] [Abstract][Full Text] [Related]
18. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Wang LQ; Chim CS Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645 [TBL] [Abstract][Full Text] [Related]
20. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]